New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States (1985)

Chapter: Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate

Previous Chapter: Appendix A: Some Examples of the Application of Project Selection Method
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 153
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 154
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 155
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 156
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 157
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 158
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 159
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 160
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 161
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 162
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 163
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 164
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 165
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 166
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 167
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 168
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 169
Suggested Citation: "Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate." Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. doi: 10.17226/12085.
Page 170
Next Chapter: Appendix C: Prospects for Immunizing Against Bordetella pertussis
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.